A high therapeutic efficacy of polymeric prodrug nano-assembly for a combination of photodynamic therapy and chemotherapy
Open Access
- 21 November 2018
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 1 (1) , 1-13
Abstract
Combination of photodynamic therapy and chemotherapy has been emerging as a new strategy for cancer treatment. Conventional photosensitizer tends to aggregate in aqueous media, which causes fluorescence quenching, reduces reactive oxygen species (ROS) production, and limits its clinical application to photodynamic therapy. Traditional nanoparticle drug delivery system for chemotherapy also has its disadvantages, such as low drug loading content, drug leakage, and off-target toxicity for normal tissues. Here, we developed a reduction-sensitive co-delivery micelles TB@PMP for combinational therapy, which composed of entrapping a red aggregation-induced emission fluorogen (AIEgen) for photodynamic therapy and PMP that contains a reduction-sensitive paclitaxel polymeric prodrug for chemotherapy. AIEgen photosensitizer illustrates a much improved photostability and ROS production efficiency in aggregate state and PMP loads a high dose of paclitaxel and carries a smart stimuli-triggered drug release property. This co-delivery system provides a better option that replaces AIEgen photosensitizer for cancer diagnosis and therapy.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 53 references indexed in Scilit:
- Insights into the structure of class B GPCRsTrends in Pharmacological Sciences, 2014
- Polymer–drug conjugates: present state of play and future perspectivesDrug Discovery Today, 2013
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- Paclitaxel targeting to lungs by way of liposomes prepared by the effervescent dispersion techniqueArchives of Pharmacal Research, 2013
- Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapyNano Today, 2010
- Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learntAdvanced Drug Delivery Reviews, 2009
- Multifunctional nanoparticles – properties and prospects for their use in human medicineTrends in Biotechnology, 2008
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Aggregation-induced emission of 1-methyl-1,2,3,4,5-pentaphenylsiloleChemical Communications, 2001